Mercado Global Delirium Tremens (DT) – Tendências do setor e previsão para 2028

Análise e insights de mercado: Mercado global de Delirium Tremens (DT)

Espera-se que o mercado de Delirium tremens (DT) ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 4,80% no período de previsão do inquérito acima mencionado. Aumento do consumo de álcool e aumento da prevalência de doenças psicológicas.

Além disso, o aumento do número de medicamentos genéricos e as iniciativas governamentais para controlar o uso excessivo de álcool também impulsionam o crescimento do mercado. Além disso, os vigorosos esforços de investigação e desenvolvimento e o aumento do rendimento disponível funcionam como uma oportunidade para o crescimento do mercado. Mas, por vezes, os efeitos adversos relacionados com os medicamentos, o uso excessivo de benzodiazepinas e as crescentes tendências suicidas entre os utilizadores podem prejudicar o mercado global de delirium tremens (DT).

A perturbação delirium tremens está associada ao uso excessivo de álcool. Assim que o abuso de álcool cessa, o delirium tremens começa logo após 48 horas e dura 5 dias. O delirium tremens caracteriza-se por atividades convulsivas, alucinações visuais, taquicardia, hipertermia, sudação, agitação profunda confusão entre outras. O tratamento mais comum para o Delirium tremens é a benzodiazepina que varia entre o diazepam, lorazepam entre vários outros. Juntamente com estes tratamentos, a gabapentina, o clordiazepóxido também demonstrou relaxar os sintomas associados ao Delirium tremens. Além disso, a perturbação Delirium tremens resulta também em carências nutricionais que podem ser ultrapassadas pelo uso de zinco, tiamina, fosfato, magnésio, folato, entre outros nutrientes.

De acordo com a publicação do NCBI, foi relatado que o Delirium tremens é altamente prevalente em homens adultos, varia entre 17% dos homens e 36% dos homens e prevalece durante 12 meses ou durante toda a vida. A população afectada exige um tratamento eficaz e, por isso, espera-se que proporcione ao mercado um crescimento rentável.

This delirium tremens (DT) market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Delirium Tremens (DT) Market Scope and Market Size

Delirium tremens (DT) market is segmented on the basis of treatment, complications, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the delirium tremens (DT) market is segmented into antipsychotic drugs, anticonvulsants, pain medication, antiarrhythmic drugs and diuretics. Antipsychotic drugs are further sub- segmented into typical antipsychotics and atypical antipsychotics. Anticonvulsants drugs is further sub- segmented into primidone, phenobarbital, clonazepam, valproic acid, carbamazepine, phenytoin and ethosuximide. Antiarrhythmic drugs are sub segmented into amiodarone, flecainide, ibutilide, lidocaine, procainamide, propafenone, quinidine, tocainide and others. Diuretics is sub segmented into thiazide, loop, potassium sparing.
• On the basis of complications, the delirium tremens (DT) market is segmented into seizures, disorientation, hypertension, hyperthermia, respiratory failure and aspiration pneumonitis.
• On the basis of end-users, the delirium tremens (DT) market is segmented into clinics, hospitals, rehabilitation centers, others.
• On the basis of distribution channel, the delirium tremens (DT) market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others.

Delirium Tremens (DT) Market Country Level Analysis

Delirium tremens (DT) market is analysed and market size information is provided by country, treatment, complications, end-users and distribution channel as referenced above.

The countries covered in the delirium tremens (DT) market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America accounts the largest market share due to the changing lifestyles and enhanced alcohol consumption. Europe accounts the second largest market share due to increasing government initiative to ban alcohol and increasing collaboration and partnership for development of novel therapies. Asia-Pacific is expected to account for the largest market share over coming years for the delirium tremens (DT) market as China is one of the largest exporters of drugs used for treatment of delirium tremens and increasing psychological diseases.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Delirium tremens (DT) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Delirium Tremens (DT) Market Share Analysis

Delirium tremens (DT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to delirium tremens (DT) market.

The major players covered in the delirium tremens (DT) market are Lannett, polpharma, Bioindustria L.I.M., Aspen Holdings, Aspire Group, Bal Pharma Limited, Reine Life Science, SEQENS, Pfizer, Lundbeck, Genentech, USA Inc., GlaxoSmithKline Inc., Otsuka America Pharmaceutical, Inc., Johnson & Johnson Services, Inc., Lupin Pharmaceuticals, Inc., Mallinckrodt, Aurobindo Pharma USA., aurolife, Cambrex Corporation, MODASA Pharmaceuticals Pvt. Ltd., Teva Pharmaceuticals USA, Inc., Novartis AG, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-59503